Registro:

Referencias:

• Martin, D., Porphyrins (1983) Harpeŕs Review of Biochemistry, pp. 317-333. , Martin D., Mayes P., and Rodwel V. (Eds), Los Altos, CA, Lange Medical Publications
• Van Steveninck, J., Tijssen, K., Boegheim, J., Van Der Zee, J., Dubbleman, T., Photodynamic generation of hydroxyl radicals by haematoporphyrin derivative and light (1986) Photochem. Photobiol., 44, pp. 711-716
• Kennedy, J., Pottier, R., Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy (1992) J. Photochem. Photobiol. B, 14, pp. 275-292
• Marti, A., Lange, N., van den Bergh, H., Sedmera, D., Jichlinski, P., Kucera, P., Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach (1999) J. Urol., 162, pp. 546-552
• Lange, N., Jichinlinski, P., Zellweger, M., Forrer, M., Marti, A., Guillou, L., Kuchera, P., van den Bergh, H., Photodetection of early human bladder cancer based on the fluorescence of 5-aminolevulinic acid hexylester-induced protoporhyrin IX: a pilot study (1999) Br. J. Cancer, 80, pp. 185-193
• Kloek, J., Beijersbergen, G., Henegouwen, v., Prodrugs of 5-aminolevulinic acid for photodynamic therapy (1996) Photochem. Photobiol., 64, pp. 994-1000
• Kloek, J., Akkermans, W., Beijersbergen, G., Henegouwen, v., Derivatives of 5-Aminolevulinic acid for Photodynamic therapy: enzymatic conversion into protoporphyrin (1998) Photochem. Photobiol., 67, pp. 150-154
• Gaullier, J., Berg, K., Peng, Q., Anholt, H., Selbo, P., Ma, L., Moan, J., Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture (1997) Cancer Res., 57, pp. 1481-1486
• Berger, Y., Greppi, A., Siri, O., Neier, R., Jullierat-Jeanneret, L., Ethylene glycol and amino acid derivatives of 5-aminolevulinic acid as new photosensitizing precursors of Protoporphyrin IX (2000) J. Med. Chem., 43, pp. 4738-4746
• Uehlinger, P., Zellweger, M., Wagnières, G., Juillerat-Jeanneret, L., H. van den Bergh, N. Lange, 5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells (2000) J. Photochem. Photobiol. B Biol., 54, pp. 72-80
• Casas, A., Fukuda, H., Di Venosa, G., A battle photosensitisation and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy (2001) Br. J. Cancer, 85, pp. 279-284
• Casas, A., Batlle, A., Aminolevulinic acid derivatives and liposome delivery as strategies for improving 5-aminolevulinic acid-mediated photodynamic therapy (2006) Curr. Med. Chem., 13, pp. 1157-1168
• Di Venosa, G., Batlle, A., Fukuda, H., Macrobert, A., Casas, A., Distribution of 5-aminolevulinic acid derivatives and induced porphyrin kinetics in mice tissues (2006) Cancer Chemother. Pharmacol., 58, pp. 478-486
• Rodriguez, L., Batlle, A., Di Venosa, G., Battah, S., Dobbin, P., Macrobert, A., Casas, A., Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells (2006) Br. J. Pharmacol., 147, pp. 823-825
• Perotti, C., Fukuda, H., Di Venosa, G., MacRobert, A., Batlle, A., A Casas A Porphyrins synthesis from ALA derivatives for photodynamic therapy In vitro and in vivo studies (2004) Br. J. Cancer, 90, pp. 1660-1665
• Pass, H., Photodynamic therapy in oncology: mechanisms and clinical use (1993) J. Natl. Cancer Inst., 85, pp. 443-456
• Derycke, A.S., Witte, P.A., Liposomes for photodynamic therapy (2004) Adv. Drug Deliv. Rev., 56, pp. 17-30
• Konan, Y.N., Gurny, R., Allemann, E., State of the art in the delivery of photosensitizers for photodynamic therapy (2002) J. Photochem. Photobiol. B., 66, pp. 89-106
• Reddi, E., Role of delivery vehicles for photosensitizers in the photodynamic therapy of tumours (1997) J. Photochem. Photobiol. B., 37, pp. 189-195
• Fukuda, H., Paredes, S., Batlle, A.M., Tumor-localizing properties of porphyrins. In vitro studies using the porphyrin precursor, aminolevulinic acid, in free and liposome encapsulated forms (1989) Drug Des. Deliv., 5, pp. 133-139
• Casas, A., Perotti, C., Saccoliti, M., Sacca, P., Fukuda, H., Batlle, A.M., ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumour organ cultures (2002) Br. J. Cancer, 86, pp. 837-842
• Fukuda, H., Paredes, S., Batlle, A.M., Tumour-localizing properties of porphyrins. In vivo studies using free and liposome encapsulated aminolevulinic acid (1992) Comp. Biochem. Physiol. B., 102, pp. 433-436
• Casas, A., Fukuda, H., Di Venosa, G., Batlle, A.M., The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid Implications in cutaneous photodynamic sensitization (2000) Br. J. Dermatol., 143, pp. 564-572
• Pierre, M.B., Tedesco, A.C., Marchetti, J.M., Bentley, M.V., Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study (2001) BMC Dermatol., 1, p. 5
• Kosobe, T., Moriyama, E., Tokuoka, Y., Kawashima, N., Size and surface charge effect of 5-aminolevulinic Acid-containing liposomes on photodynamic therapy for cultivated cancer cells (2005) Drug Dev. Ind. Pharm., 31, pp. 623-629
• Han, I., Jun, M., Kim, S., Kim, M., Kim, J., Expression and intensity of protoporphyrin IX induced by liposomal 5-aminolevulinic acid in rat pilosebaceous unit throughout hair cycle (2005) Arch. Dermatol. Res., 297, pp. 210-217
• Di Venosa, G., Hermida, L., Batlle, A., Fukuda, H., Defain, M.V., Mamone, L., Rodriguez, L., Casas, A., Characterisation of liposomes containing aminolevulinic acid and derived esters (2008) J. Photochem. Photobiol. B Biol., 92, pp. 1-9
• Takeya, H., Preparation of 5-aminolevulinic acid alkyl ethers as herbicides (1992) Chem. Abs., 116, pp. 189633 m
• Fry, D., White, C., Goldman, D., Rapid separation of low molecular weight solutes from liposomes without dilution (1978) Anal. Biochem., 90, pp. 809-815
• Stewart, J., Colorimetric determination of phospholipids with ammonium ferrothiocyanate (1959) Anal. Biochem., 10, pp. 10-14
• Werbajh, S., Urtereger, A.J., Puricelli, L.I., de Lustig, E.S., Bal de Kier Joffe, E., Kornblihtt, A.R., Downregulation of fibronectin transcription in highly metastatic adenocarcinoma cells (1998) FEBS Lett., 440, pp. 277-281
• Denizot, F., Lang, R., Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability (1986) J. Immunol. Methods, 89, pp. 271-277
• Workman, P., Balmain, A., Hickman, J., United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (1998) Br. J. Cancer, 77, pp. 1-10. , (second Edition)
• Van den Akker, J., Iani, V., Star, W., Sterenborg, H., Moan, J., Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in Protoporphyrin IX fluorescence kinetics and the role of the stratum corneum (2000) Photochem. Photobiol., 72, pp. 681-689
• Casas, A., Batlle, A.M., Butler, A.R., Robertson, D., Brown, E.H., MacRobert, A., Riley, P.A., Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures (1999) Br. J. Cancer, 80, pp. 1525-1532
• Di Venosa, G., Fukuda, H., Perotti, C., Batlle, A., Casas, A., A simple method for separating ALA from ALA derivatives using ionic exchange chromatography (2004) J. Photochem. Photobiol. B, 75, pp. 157-163
• Mauzerall, M., Granick, S., The occurrence and determination of 5-aminolevulinic acid and porphobilinogen in urine (1956) J. Biol. Chem., 219, pp. 435-437
• El Maghraby, G., Barry, B., Williams, A., Liposomes and skin: from drug delivery to model membranes (2008) Eur. J. Pharm. Sci., 34, pp. 203-222
• Har-el, Y., Kato, Y., Intracellular delivery of nanocarriers for cancer therapy (2007) Curr. Nanosci., 3, pp. 329-338

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------